BTIG Starts United Therapeutics Corp. (UTHR) at Neutral

Go back to BTIG Starts United Therapeutics Corp. (UTHR) at Neutral

Barclays Starts United Therapeutics Corp. (UTHR) at Equalweight

January 6, 2015 8:35 AM EST

Barclays initiated coverage on United Therapeutics Corp. (NASDAQ: UTHR) with an Equalweight rating and a price target of $135.00.

For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.

Shares of United Therapeutics Corp. closed at $126.83 yesterday.

... More